NEOS Investment Management’s Cogent Biosciences COGT Stock Holding History

NEOS Investment Management’s Portfolio COGT Stock Details COGT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-107,924	Closed	-$3.83M	–	598
2025 Q4	$3.83M	Buy	107,924 +18,001	+20%	+$506K	0.02%	374
2025 Q3	$1.29M	Sell	89,923 -27,716	-24%	-$328K	0.01%	487
2025 Q2	$845K	Buy	117,639 +46,076	+64%	+$255K	0.01%	484
2025 Q1	$429K	Buy	71,563 +19,637	+38%	+$154K	0.01%	529
2024 Q4	$405K	Buy	51,926 +5,111	+11%	+$50.9K	0.01%	531
2024 Q3	$506K	Buy	46,815 +2,959	+7%	+$28.8K	0.02%	490
2024 Q2	$370K	Buy	43,856 +25,555	+140%	+$194K	0.02%	495
2024 Q1	$123K	Buy	18,301 +5,365	+41%	+$33.2K	0.01%	562
2023 Q4	$76.1K	Buy	+12,936	New	+$99.1K	0.01%	509

Other funds holding COGT

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

NEOS Investment Management's COGT Position: Q1 2026 in Review

NEOS Investment Management sold out of Cogent Biosciences (COGT) in Q1 2026, closing a stake of 107,924 shares — an estimated $3.83M sold.

NEOS Investment Management first reported a position in COGT in Q4 2023 and held it in 9 quarters. The position peaked at $3.83M in Q4 2025. 305 funds tracked by Wall St. Rank hold COGT as of Q1 2026.

NEOS Investment Management reported no remaining Cogent Biosciences position as of Q1 2026 after selling out during the quarter.
NEOS Investment Management sold 107,924 Cogent Biosciences shares in Q1 2026, an estimated $3.83M.
NEOS Investment Management first reported a position in Cogent Biosciences in Q4 2023 and held it in 9 quarters.
NEOS Investment Management's Cogent Biosciences position peaked at $3.83M in Q4 2025.
305 funds tracked by Wall St. Rank held Cogent Biosciences as of Q1 2026.

Based on NEOS Investment Management's 13F filing for Q1 2026, filed 15 May 2026.